lidocaine in-situ gel
Druglidocaine in-situ gel
NCT Number: NCT02943135
Intrauterine device can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the insertion tube, and removing the tube; and placement of the device in the uterus.
Looking for future studies?
Notify Me20 year–50 year
Female
Interventional
Phase 3
Ahmed Abbas, Assiut, Cairo Governorate, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
lidocaine in-situ gel
placebo in-situ gel
Time frame: 30 min
Assiut University
Other
Effect of Self-administered Lidocaine In-situ Gel on Intrauterine Device Insertion Pain: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04473508
AdverseEvent, Morphine
Nîmes, Gard, France
View Trial DetailsNCT04586712
Muscle Injury, Pain Relief
Gainesville, Florida, United States
View Trial DetailsNCT06456177
Pain Relief
Haifa, Israel
View Trial DetailsNCT00580489
Adverse Events, Agnosia
Cleveland, Ohio, United States
View Trial Details